HSR&D Research Career Scientist Award
高铁
基本信息
- 批准号:10489275
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-10-01 至 2026-09-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse eventAffectAreaAwardBudgetsCaringClinicClinicalClinical ManagementCollaborationsCommunitiesComplexDataDedicationsDoctor of PhilosophyEmployee EngagementEmploymentEpidemiologistEvaluationFoundationsFundingGrantHealthHealth PersonnelHealth PolicyHealth PrioritiesHealth ServicesHealth Services AdministrationHealth Services ResearchHealth systemHealthcareIndividualInstitutionInternationalKnowledgeLeadLeadershipLearningMental DepressionMental HealthMental Health ServicesMentorsMentorshipMethodsMichiganOutcomeOverdosePatient CarePatientsPeer ReviewPerinatalPersonal SatisfactionPharmaceutical PreparationsPhysiciansPoliciesPolicy MakerPolicy MakingPostpartum WomenPregnant WomenPrimary CarePrincipal InvestigatorProductivityProviderPsychologistPublicationsQuality of CareResearchResearch MethodologyResearch PersonnelResearch PriorityResourcesRoleScientistServicesState GovernmentSubstance Use DisorderSuicideSuicide preventionSystemTrainingTreatment outcomeUnited States Dept. of Health and Human ServicesUnited States Food and Drug AdministrationUnited States National Institutes of HealthVeteransVeterans Health AdministrationWomen&aposs HealthWorkbehavioral healthburnoutcare costscareercareer life balancechild bearingclinical centerdesigndisabilityexperiencefunctional outcomeshealth service usehigh riskimprovedinnovationnext generationpharmacy benefitprogramsresearch and developmentsevere mental illnesstherapy development
项目摘要
Behavioral health (BH) conditions, including mental health and substance use disorders, remain common and
persistent among Veterans Health Administration (VHA) patients. Several VHA key priority areas coincide with
BH conditions, including disability, overdose, suicide, and women's health. VHA remains a national leader in
providing high-quality BH treatment and serves as an early responder to policies and programs designed to
improve health and wellbeing for individuals experiencing these conditions. VHA must develop and evaluate
new strategies to manage and resolve the complicated array of problems facing Veterans with BH conditions and
their providers.
Kara Zivin, PhD, MS, MA has focused on improving VHA BH services using used mixed methods research and
evaluation approaches. The three primary thematic aims of her work include: 1) to continue research to evaluate
the impacts of health policies and system initiatives on outcomes among Veterans with BH conditions, leading
to intervention development, implementation, dissemination, and targeted policymaking; 2) to extend research
to improve Veteran functional outcomes including disability and employment among those with BH conditions
and enhance VHA clinician wellbeing; and 3), to develop and lead women's health research to improve Veterans'
perinatal BH. These three thematic areas directly relate to positive treatment outcomes, including overall
function and wellbeing, and reducing the likelihood of adverse events among Veterans with BH conditions.
Dr. Zivin's has demonstrated her contributions to these areas through her externally funded research with
support from VA Health Services Research and Development (HSR&D), National Institutes of Health (NIH), and
Michigan Department of Health and Human Services (MDHHS) among others in addition to over 160 peer-
reviewed scientific publications. Dr. Zivin has actively mentored ten early career investigators and/or trainees
within the VA and has served in key leadership and service roles locally within the Ann Arbor VA Center of
Innovation (COIN) and nationally within the VHA.
Given her active and productive research portfolio and demonstrated commitment to mentoring colleagues in
developing VHA research careers, Dr. Zivin is a strong candidate for a Health Services Research Career Scientist
Award. The proposed Research Career Scientist Award will support her continued research, an expanded role in
mentorship and training of the next generation of HSR&D researchers, and targeted VHA service designed to
enhance and extend the reach and impact of her research and mentoring. Her research portfolio has the potential
to address some of the most critical and vexing BH-related priorities in VHA and improve care for some of the
most challenging and highest-risk Veterans treated within the VHA system.
行为健康(BH)状况,包括精神健康和物质使用障碍,仍然很常见,
在退伍军人健康管理局(VHA)患者中持续存在。VHA的几个关键优先领域与
BH条件,包括残疾,过量,自杀和妇女的健康。VHA仍然是国家领导者,
提供高质量的BH治疗,并作为政策和计划的早期响应者,
改善经历这些条件的个人的健康和福祉。VHA必须开发和评估
新的战略,以管理和解决退伍军人面临的一系列复杂的问题与BH条件,
他们的供应商。
Kara Zivin,博士,硕士,硕士,专注于使用混合方法研究和改进VHA BH服务,
评价方法。她工作的三个主要主题目标包括:1)继续研究,
卫生政策和系统举措对患有BH疾病的退伍军人的影响,
干预措施的制定、实施、传播和有针对性的决策; 2)扩大研究
改善退伍军人的功能结果,包括BH患者的残疾和就业
提高VHA临床医生的福祉; 3)发展和领导妇女健康研究,以改善退伍军人的健康状况。
围产期BH。这三个主题领域直接关系到积极的治疗结果,包括总体
功能和福祉,并减少与BH条件退伍军人之间的不良事件的可能性。
博士Zivin通过她的外部资助的研究证明了她对这些领域的贡献,
来自VA卫生服务研究与发展(HSR&D),美国国立卫生研究院(NIH)的支持,以及
密歇根州卫生和人类服务部(MDHHS)等,除了160多个同行-
审查科学出版物。Zivin博士积极指导了10名早期职业调查员和/或学员
在退伍军人事务部,并曾在安阿伯退伍军人事务中心担任关键的领导和服务角色,
创新(COIN)和VHA内的国家。
鉴于她积极和富有成效的研究组合,并表现出致力于指导同事,
发展VHA研究事业,Zivin博士是卫生服务研究职业科学家的有力候选人
奖拟议的研究职业科学家奖将支持她继续研究,扩大作用,
下一代HSR&D研究人员的指导和培训,以及旨在
加强和扩大她的研究和指导的范围和影响。她的研究成果有可能
解决VHA中一些最关键和最令人烦恼的BH相关优先事项,并改善对一些
最具挑战性和最高风险的退伍军人在VHA系统内治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kara Zivin其他文献
Kara Zivin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kara Zivin', 18)}}的其他基金
Disparities in utilization and delivery outcomes for women with perinatal mood and anxiety disorders (PMAD): groundwork for state policymaking
患有围产期情绪和焦虑症 (PMAD) 的妇女在利用和分娩结果方面的差异:国家政策制定的基础
- 批准号:
10305975 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Disparities in utilization and delivery outcomes for women with perinatal mood and anxiety disorders (PMAD): groundwork for state policymaking
患有围产期情绪和焦虑症 (PMAD) 的妇女在利用和分娩结果方面的差异:国家政策制定的基础
- 批准号:
10618967 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Relationship between mental health coverage and outcomes for privately insured women with perinatal mood and anxiety disorders (PMAD)
患有围产期情绪和焦虑症 (PMAD) 的私人受保女性的心理健康保险与结果之间的关系
- 批准号:
10409775 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Caring for the caregiver: predictors and consequences of VA mental health provider burnout
照顾看护者:退伍军人管理局心理健康提供者倦怠的预测因素和后果
- 批准号:
9710109 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Relationship between mental health coverage and outcomes for privately insured women with perinatal mood and anxiety disorders (PMAD)
患有围产期情绪和焦虑症 (PMAD) 的私人受保女性的心理健康保险与结果之间的关系
- 批准号:
10197277 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Caring for the caregiver: predictors and consequences of VA mental health provider burnout
照顾看护者:退伍军人管理局心理健康提供者倦怠的预测因素和后果
- 批准号:
10570155 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Relationship between mental health coverage and outcomes for privately insured women with perinatal mood and anxiety disorders (PMAD)
患有围产期情绪和焦虑症 (PMAD) 的私人受保女性的心理健康保险与结果之间的关系
- 批准号:
10197811 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Unintended Consequences: The Impact of VA Antipsychotic Reduction Efforts in Dementia
意想不到的后果:减少 VA 抗精神病药物治疗对痴呆症的影响
- 批准号:
9873826 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Unintended Consequences: The Impact of VA Antipsychotic Reduction Efforts in Dementia
意想不到的后果:减少 VA 抗精神病药物治疗对痴呆症的影响
- 批准号:
10308378 - 财政年份:2017
- 资助金额:
-- - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
-- - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
-- - 项目类别: